amiodarone has been researched along with dobutamine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Daniels, CJ; Franklin, WH; Hammond, S; Schutte, DA | 1 |
| Hoshizaki, H; Iwasaki, T; Kasama, S; Nagai, R; Oshima, S; Suzuki, T; Taniguchi, K; Toyama, T | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kontoyannis, DA; Moulopoulos, SD; Nanas, JN; Stamatelopoulos, SF; Tsagalou, EP | 1 |
| Anastasiou-Nana, MI; Kanakakis, J; Moon, T; Nanas, JN; Nanas, SN; Terrovitis, JV; Tsagalou, EP | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Terrovitis, JV; Tsagalou, EP | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ | 1 |
| Dias da Silva, VJ; Fazan, R; Salgado, HC; Salgado, MC; Santana Filho, VJ; Simões, GM | 1 |
| Bonios, M; Drakos, SG; Kaldara, E; Kanakakis, JV; Katsaros, F; Nanas, JN; Nanas, S; Pantsios, C | 1 |
| Brecelj, A; Knezevic, I; Kranjec, I; Mirkovic, T; Noc, M | 1 |
| Jie, S; Xiaohu, L; Xiaoyang, T; Yanning, Q; Yu, C; Zhengnian, D | 1 |
| Ekin, S; Hancı, V; Kiraz, HA; Ömür, D; Uyan, B; Yurtlu, BS | 1 |
| Semenas, E; Sharma, HS; Wiklund, L | 1 |
| Aissaoui, N; Alazard, M; El-Aissaoui, M; Faisy, C; Funck-Brentano, C; Hulot, JS; Le-Heuzey, JY; Salem, JE; Urien, S | 1 |
2 review(s) available for amiodarone and dobutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Extrinsic left main compression: review of the literature.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Aorta; Aortic Valve; Coronary Stenosis; Dobutamine; Drug-Eluting Stents; Heart Arrest, Induced; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Norepinephrine; Risk Factors; Stroke Volume; Tricuspid Valve; Ventricular Function, Left | 2009 |
4 trial(s) available for amiodarone and dobutamine
| Article | Year |
|---|---|
Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
Topics: Administration, Oral; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Creatinine; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Sodium; Stroke Volume; Survival Rate | 2001 |
Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
Topics: Administration, Oral; Amiodarone; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Survival Rate; Vasodilator Agents | 2004 |
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Remodeling | 2006 |
The effect of amiodarone on cardiac rhythm after cardiopulmonary bypass in patients with atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; China; Dobutamine; Elective Surgical Procedures; Electric Countershock; Heart Rate; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Intraoperative Care; Mitral Valve; Recovery of Function; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2010 |
14 other study(ies) available for amiodarone and dobutamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Acute pulmonary toxicity in an infant from intravenous amiodarone.
Topics: Acute Disease; Amiodarone; Bronchoalveolar Lavage Fluid; Dobutamine; Humans; Infant; Infant, Newborn; Injections, Intravenous; Lung Diseases; Macrophages; Male; Microscopy, Electron; Respiratory Insufficiency; Sotalol; Tachycardia | 1997 |
[Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Digitalis Glycosides; Diuretics; Dobutamine; Echocardiography; Female; Humans; Male; Middle Aged; Stroke Volume; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Function, Left | 2000 |
The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
Topics: Administration, Oral; Aged; Amiodarone; Cardiomyopathy, Dilated; Dobutamine; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Survival Analysis; Treatment Outcome | 2006 |
Negative inotropic and lusitropic effects of intravenous amiodarone in conscious rats.
Topics: Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Pressure; Consciousness; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure | 2007 |
Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2009 |
Precipitation in Gallipoli: sugammadex / amiodarone & sugammadex / dobutamine & sugammadex / protamine.
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Chemical Precipitation; Chemistry, Pharmaceutical; Dobutamine; Drug Incompatibility; gamma-Cyclodextrins; Humans; Sugammadex | 2013 |
Adrenaline increases blood-brain-barrier permeability after haemorrhagic cardiac arrest in immature pigs.
Topics: Amiodarone; Animals; Blood-Brain Barrier; Capillary Permeability; Cardiopulmonary Resuscitation; Cerebrovascular Circulation; Dobutamine; Electric Countershock; Enzyme Activation; Epinephrine; Fluid Therapy; Heart Arrest; Hemodynamics; Hemorrhage; Intracranial Pressure; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Sus scrofa; Swine; Vasopressins; Ventricular Fibrillation | 2014 |
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Critical Illness; Dobutamine; Drug Design; Female; Heart Rate; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Sympathomimetics; Tachycardia | 2016 |